ClinConnect ClinConnect Logo
Search / Trial NCT05893745

Effectiveness of Dermoneuromodulation Techniques in Patients With Non-specific Chronic Neck Pain: A Randomized Controlled Trial

Launched by AHRAM CANADIAN UNIVERSITY · May 30, 2023

Trial Information

Current as of August 02, 2025

Unknown status

Keywords

ClinConnect Summary

This clinical trial is investigating a new treatment option called dermoneuromodulation (DNM) for people with chronic neck pain that doesn't have a clear cause. Chronic neck pain is a common issue that can affect daily activities and quality of life. DNM is a gentle, hands-on technique designed to help relieve pain and improve movement by interacting with the body’s nervous system. This study aims to determine if DNM actually helps people feel better and function more normally.

To participate in the trial, individuals must be between the ages of 25 and 40, have been experiencing non-specific chronic neck pain for at least three months, and rate their pain at a 5 out of 10 or higher. Participants should not have any serious underlying conditions causing their neck pain, like fractures or tumors. Those who join the trial will receive the DNM treatment and will be monitored to see how effective it is in reducing their pain and improving their overall condition. If you or a loved one are interested in learning more about this study, it could be a valuable opportunity to explore a potential new way to manage neck pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Recurrent history of non-specific chronic neck pain (NSCNP) of not less than 3 months duration.
  • Pain level greater than or equal to 5/10 on the Numeric Pain Rating Scale (NPRS).
  • Age between 25 to 40 years.
  • Both male and female participants.
  • * Diagnosis of non-specific chronic neck pain confirmed by a licensed physiotherapist or physician using a combination of the following criteria:
  • Absence of specific pathologies or conditions causing neck pain (e.g., disc prolapse, tumor of the cervical spine, whiplash injury, cervical fractures, or cervicogenic headache) as assessed by clinical examination and medical history.
  • * Presence of at least three of the following signs and symptoms:
  • 1. Restricted cervical range of motion.
  • 2. Pain provoked or increased with neck movement or sustained neck postures.
  • 3. Palpable muscle tension or tenderness in the neck or upper back region.
  • 4. Referred pain or symptoms to the shoulders, upper back, or arms.
  • Neck pain not attributed to a specific cause after careful evaluation, including imaging studies (e.g., X-ray, MRI, or CT scan) if deemed necessary by the clinician.
  • Exclusion Criteria:
  • Serious pathology such as specific neck pain due to disc prolapse, tumor of the cervical spine, whiplash injury, cervical fractures, or cervicogenic headache.
  • Any neurological signs consistent with nerve root compression.
  • Prior surgery in the cervical region.
  • Inability to comply with the exercise program or attend scheduled sessions.
  • Contraindications to dermoneuromodulation techniques, such as active skin infections or severe inflammatory skin conditions.

About Ahram Canadian University

Ahram Canadian University is a distinguished educational institution committed to advancing research and innovation in the field of healthcare. As a clinical trial sponsor, the university leverages its academic expertise and state-of-the-art facilities to conduct rigorous research studies that contribute to the understanding of medical treatments and interventions. By fostering collaboration among researchers, healthcare professionals, and industry partners, Ahram Canadian University aims to enhance patient outcomes and drive the development of evidence-based practices in medicine. Through its commitment to ethical standards and scientific integrity, the university plays a pivotal role in shaping the future of healthcare research.

Locations

Al ḩayy Ath Thāmin, Giza, Egypt

Patients applied

0 patients applied

Trial Officials

Amal Fawzy, Ph.d

Study Director

Faculty of Physical Therapy, Ahram Canadian University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported